Aberrant serum adiponectin levels in women with uterine leiomyomas

Gynecologic and Obstetric Investigation

Volumn 58, Issue 3, 2004, Pages 160-163

  Chen, Hung Sheng ^a   Chan, Te Fu ^a   Chung, Yueh Fang ^a   Su, Jinu Huang ^a   Yuan, Shyng Shiou F ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

Author keywords

Adiponectin; Hemoglobin; Hysterectomy; Insulin resistance; Insulin like growth factor I; Leiomyomas

Indexed keywords

ADIPONECTIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; UTERUS MYOMA;

ADIPONECTIN; ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HEMOGLOBINS; HUMANS; HYSTERECTOMY; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEIOMYOMA; LINEAR MODELS; RADIOIMMUNOASSAY; UTERINE NEOPLASMS;

EID: 5644244181     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079553     Document Type: Article

References (22)

1. Wilcox LS, Koonin LM, Pokras R, Strauss LT, Xia Z, Peterson HB: Hysterectomy in the United States, 1988-1990. Obstet Gynecol 1994;83:549-553.
2. Haney AF: Clinical decision making regarding leiomyomata: What we need in the next millennium. Environ Health Perspect 2000;108:835-839.
3. Ichimura T, Kawamura N, Ito F, Shibata S, Minakuchi K, Tsujimura A, Umesaki N, Ogita S: Correlation between the growth of uterine leiomyomata and estrogen and progesterone receptor content in needle biopsy specimens. Fertil Steril 1998;70:967-971.
4. Sadan O, van Iddekinge B, van Gelderen CJ, Savage N, Becker PJ, van der Walt LA, Robinson M: Oestrogen and progesterone receptor concentrations in leiomyoma and normal myometrium. Ann Clin Biochem 1987;24:263-267.
5. Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, Youngren JF, Havel PJ, Pratley RE, Bogardus C, Tataranni PA: Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 2002;50:1884-1888.
6. Havel PJ: Control of energy homeostasis and insulin action by adipocyte hormones: Leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol 2002;13:51-59.
7. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Paradoxical decrease of an adiposespecific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
8. Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, Okazaki Y, Ishii T, Nishikai K, Saruta T: Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond) 2002;103:137-142.
9. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM: Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001;86:3815-3819.
10. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE: The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001;7:947-953.
11. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-1599.
12. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-1935.
13. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y: Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 1999;100:2473-2476.
14. Berg AH, Combs TP, Scherer PE: ACRP30/ adiponectin: An adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002;13:84-89.
15. Chan TF, Su JH, Chung YF, Chang HL, Yuan SS: Decreased serum leptin levels in women with uterine leiomyomas. Acta Obstet Gynecol Scand 2003;82:173-176.
16. Nevadunsky NS, Bachmann GA, Nosher J, Yu T: Women's decision-making determinants in choosing uterine artery embolization for symptomatic fibroids. J Reprod Med 2001;46:870-874.
17. Suikkari AM, Koivisto VA, Koistinen R, Seppala M, Yki-Jarvinen H: Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin. J Clin Endocrinol Metab 1989;68:135-140.
18. Suikkari AM, Koivisto VA, Rutanen EM, Yki-Jarvinen H, Karonen SL, Seppala M: Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 1988;66:266-272.
19. Rutanen EM, Pekonen F: Insulin-like growth factors and their binding proteins. Acta Endocrinol (Copenh) 1990;123:7-13.
20. Strawn EY Jr, Novy MJ, Burry KA, Bethea CL: Insulin-like growth factor I promotes leiomyoma cell growth in vitro. Am J Obstet Gynecol 1995;172:1837-1844.
21. van der Ven LT, Gloudemans T, Roholl PJ, van Buul-Offers SC, Bladergroen BA, Welters MJ, Sussenbach JS, den Otter W: Growth advantage of human leiomyoma cells compared to normal smooth-muscle cells due to enhanced sensitivity toward insulin-like growth factor I. Int J Cancer 1994;59:427-434.
22. Abate N, Haffner SM, Garg A, Peshock RM, Grundy SM: Sex steroid hormones, upper body obesity, and insulin resistance. J Clin Endocrinol Metab 2002;87:4522-4527.